Clinical Trial Update: Evaluation of Fusion Rate Using K2M VESUVIUS® Demineralized Fibers With K2M EVEREST® Spinal System

View source ↗

Summary

Clinical trial evaluating fusion rate with K2M VESUVIUS demineralized fibers and EVEREST spinal system was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Disc Disease
• Spinal Stenosis
• Spondylolisthesis

Drugs mentioned

• EVEREST Spinal System (spinal implant system)
• VESUVIUS Demineralized Fibers (demineralized bone fiber)

Snippet

Sponsor: K2M, Inc. | Conditions: Spinal Stenosis, Spondylolisthesis | Status: TERMINATED | Results posted: 2021-03-01